DE69834638D1 - Heilende zusammensetzung für intraokulare hypertension oder glaukom - Google Patents

Heilende zusammensetzung für intraokulare hypertension oder glaukom

Info

Publication number
DE69834638D1
DE69834638D1 DE69834638T DE69834638T DE69834638D1 DE 69834638 D1 DE69834638 D1 DE 69834638D1 DE 69834638 T DE69834638 T DE 69834638T DE 69834638 T DE69834638 T DE 69834638T DE 69834638 D1 DE69834638 D1 DE 69834638D1
Authority
DE
Germany
Prior art keywords
glaucoma
healing composition
intraocular hypertension
intraocular
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834638T
Other languages
English (en)
Other versions
DE69834638T2 (de
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of DE69834638D1 publication Critical patent/DE69834638D1/de
Application granted granted Critical
Publication of DE69834638T2 publication Critical patent/DE69834638T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69834638T 1997-10-13 1998-09-30 Zusammensetzung zur Behandlung von Augenhypertension oder Glaukom Expired - Lifetime DE69834638T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27854097 1997-10-13
JP27854097 1997-10-13
PCT/JP1998/004399 WO1999018969A1 (fr) 1997-10-13 1998-09-30 Composition curative de l'hypertension intraoculaire ou du glaucome

Publications (2)

Publication Number Publication Date
DE69834638D1 true DE69834638D1 (de) 2006-06-29
DE69834638T2 DE69834638T2 (de) 2007-05-10

Family

ID=17598695

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69834638T Expired - Lifetime DE69834638T2 (de) 1997-10-13 1998-09-30 Zusammensetzung zur Behandlung von Augenhypertension oder Glaukom

Country Status (9)

Country Link
US (1) US6329426B1 (de)
EP (1) EP0979652B1 (de)
AT (1) ATE326972T1 (de)
CA (1) CA2274708A1 (de)
DE (1) DE69834638T2 (de)
DK (1) DK0979652T3 (de)
ES (1) ES2265166T3 (de)
HK (1) HK1024170A1 (de)
WO (1) WO1999018969A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5011548B2 (ja) * 1998-12-25 2012-08-29 株式会社アールテック・ウエノ 高眼圧症あるいは緑内障の処置用医薬組成物
AU2002243795A1 (en) * 2001-01-30 2002-08-12 Pharmaceutical Research Corporation Use of prostaglandin analogs for treatment of cardiac conditions
ATE422894T1 (de) * 2002-03-21 2009-03-15 Cayman Chem Co Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom
JP2005519978A (ja) * 2002-03-28 2005-07-07 スキャンポ・アーゲー 高眼圧症および緑内障の処置方法
US20020168424A1 (en) * 2002-07-31 2002-11-14 Dr. Mohsen Shahinpoor Nitric oxide (NO) donor+cGMP-PDE5 inhibitor as a topical drug for glaucoma
US6864282B2 (en) * 2002-08-05 2005-03-08 Allergan, Inc. 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
US7320871B2 (en) * 2003-07-14 2008-01-22 Allergan, Inc. Human prostaglandin FP receptor variants and methods of using same
WO2007105691A1 (ja) * 2006-03-13 2007-09-20 R-Tech Ueno, Ltd. 水性組成物
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
EP2127638A1 (de) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom
WO2017089980A1 (en) * 2015-11-26 2017-06-01 Cadila Healthcare Limited Dual ppar modulators for the treatment of diabetic retinopathy and diabetic eye diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209939B (en) 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
ES2317964T5 (es) * 1988-09-06 2015-02-20 Pfizer Health Ab Derivado de prostaglandina-F2alfa para el tratamiento de glaucoma o hipertensión ocular
GB8916944D0 (en) 1989-07-25 1989-09-13 Ici Plc Composite particle dispersions
ATE207360T1 (de) * 1992-03-19 2001-11-15 R Tech Ueno Ltd Behandlung von augenhochdruck mit betablockern und prostansäurederivaten
AU665287B2 (en) * 1992-12-21 1995-12-21 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
WO1997023225A1 (en) * 1995-12-22 1997-07-03 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop

Also Published As

Publication number Publication date
DK0979652T3 (da) 2006-09-11
CA2274708A1 (en) 1999-04-22
US6329426B1 (en) 2001-12-11
EP0979652B1 (de) 2006-05-24
EP0979652A4 (de) 2003-05-14
DE69834638T2 (de) 2007-05-10
HK1024170A1 (en) 2000-10-05
EP0979652A1 (de) 2000-02-16
ES2265166T3 (es) 2007-02-01
WO1999018969A1 (fr) 1999-04-22
ATE326972T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
ES2458493T8 (es) Composición oftálmica tópica de fluprostenol para el tratamiento del glaucoma y de la hipertensión ocular
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
ES2193901T1 (es) Derivados de prostaglandina para el tratamiento de glaucoma o hipertension ocular.
ATE326972T1 (de) Heilende zusammensetzung für intraokulare hypertension oder glaukom
ATE223200T1 (de) Einen carboanhydrase-hemmer und xanthangummi enthaltendes augenarzneimittel
DE3578584D1 (de) Therapeutische und vorbeugende ophthalmische loesung fuer intraokulaere hypertension und glaukoma.
AU5355498A (en) 15-fluoro prostaglandins as ocular hypotensives
ATE216889T1 (de) Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE289198T1 (de) Verwendung von flunarizin zur topischen behandlung ocularem hochdruck
DE69829227D1 (de) Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom

Legal Events

Date Code Title Description
8364 No opposition during term of opposition